Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
39.14
-0.25 (-0.63%)
Dec 20, 2024, 4:00 PM EST - Market closed
Amphastar Pharmaceuticals Market Cap
Amphastar Pharmaceuticals has a market cap or net worth of $1.88 billion as of December 20, 2024. Its market cap has decreased by -32.56% in one year.
Market Cap
1.88B
Enterprise Value
2.26B
1-Year Change
-32.56%
Ranking
Category
Stock Price
$39.14
Market Cap Chart
Since June 25, 2014, Amphastar Pharmaceuticals's market cap has increased from $374.20M to $1.88B, an increase of 402.91%. That is a compound annual growth rate of 16.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2024 | 1.89B | -36.08% |
| Dec 29, 2023 | 2.96B | 118.81% |
| Dec 30, 2022 | 1.35B | 21.52% |
| Dec 31, 2021 | 1.11B | 16.65% |
| Dec 31, 2020 | 955.30M | 5.51% |
| Dec 31, 2019 | 905.40M | -1.31% |
| Dec 31, 2018 | 917.40M | 3.71% |
| Dec 29, 2017 | 884.60M | 4.34% |
| Dec 30, 2016 | 847.80M | 32.34% |
| Dec 31, 2015 | 640.60M | 23.57% |
| Dec 31, 2014 | 518.40M | 38.54% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Belite Bio | 1.96B |
| Supernus Pharmaceuticals | 1.95B |
| Akero Therapeutics | 1.95B |
| Harmony Biosciences Holdings | 1.93B |
| Soleno Therapeutics | 1.90B |
| ImmunityBio | 1.87B |
| CG Oncology | 1.87B |
| UFP Technologies | 1.86B |